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Abstract: Cyclopiazonic acid (CPA) is an indole-tetramic acid neurotoxin produced by 
some of the same strains of A. flavus that produce aflatoxins and by some Aspergillus 
oryzae strains. Despite its discovery 40 years ago, few reviews of its toxicity and 
biosynthesis have been reported. This review examines what is currently known about the 
toxicity of CPA to animals and humans, both by itself or in combination with other 
mycotoxins. The review also discusses CPA biosynthesis and the genetic diversity of CPA 
production in A. flavus/oryzae populations.  
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1. Introduction  
 
Mycotoxins are fungal secondary metabolites which, if ingested, can evoke a wide range of toxic 
responses and disease conditions in higher vertebrates. Cyclopiazonic acid (α-cyclopiazonic acid; 
CPA, Figure 1) is an indole-tetramic acid mycotoxin produced by the ubiquitous genera of molds 
Aspergillus and Penicillium. Beside colonizing various grains and seeds [1,2], these molds can grow 
on many food substrates, such as cheese and meat products [3–5]. Therefore, CPA can contaminate a 
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number of agricultural commodities, animal feeds, and food sources. This toxin has been found in 
edible tissue in poultry, milk, and eggs [6–8] presumptively due to animals’ consumption of 
contaminated feeds. Despite the wide presence of CPA, few incidents of animal mycotoxicosis and no 
confirmed incident of human poisoning have been attributed to CPA. Despite its early discovery, the 
benign nature of CPA has rendered it to receive much less attention of the mycotoxin research 
community than its counterparts such as aflatoxins, trichothecenes, fumonisins and ochratoxins in the 
past two decades. 
Figure 1. Structure of α-CPA. 
 
 
The chemistry and biochemistry of the synthesis of CPA, which was carried out primarily in a 
Penicillium strain, received considerable attention in the 1970s. Some intermediates and enzymes 
involved in their formation and/or conversions were purified (for a review, see [9] and references 
therein). The chemical characterization of CPA also has elicited a tremendous interest in studies of 
biologically active natural products containing the tetramic acid structural motif, an important class of 
nitrogen-containing heterocycles [10–12]. The detailed revelation of CPA formation, especially the 
aspects of molecular biology and enzymatic mechanisms, however, had been lacking until the recent 
identification of three clustered biosynthetic genes in Aspergillus flavus and closely related Aspergillus 
oryzae [13–15]. This review aims to provide an historic overview of CPA studies and the most recent 
progress made in the elucidation of CPA biosynthesis. 
 
2. CPA-Producing Fungi 
 
Cyclopiazonic acid is named after the strain, Penicillium cyclopium Westling [16], from which it 
was originally isolated. However, P. cyclopium or its synonym P. aurantiogriseum [17] have not been 
found to make CPA, and the CPA-producing strain originally isolated (CSIR 1082) was later identified 
as P. griseofulvum Dierckx [18]. Other species of Penicillium including P. griseofulvum,  
P. camemberti, P. urticae and P. commune have been reported to consistently produce CPA [19]. 
Other species of P. chrysogenum, P. nalgiovense, P. crustosum, P. hirsutum and P. viridicatum also 
have been reported to produce CPA [20] but CPA production by these taxa has not been confirmed. 
Certain Aspergillus species such as A. flavus, A. oryzae, A. fumigatus, A. versicolor, and A. tamarii 
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also produce CPA [21–23]. In a recent survey, Vinokurova et al. [24] found that 30% of the   
A. fumigatus and A. phoenicis strains but only one of 21 A. versicolor strains were able to produce 
CPA. The low incidence of CPA production by A. versicolor warrants a further examination since A. 
versicolor Tiraboschi originally reported to produce CPA [25] was later identified as A. oryzae [26]. 
 
Table 1. Percentage of CPA-producing A. flavus isolates from various regions of the world. 
Sources  No.
a  BG
b  AF/CPA AF/−  −/CPA −/−  References 
Peanuts, soybean, 
wheat, Argentina 
87  5   27  2  57  14  [27] 
Peanuts, Argentina  38  2   79  0  21  0  [28] 
Peanuts, Argentina  29  3   49  3  24  24  [29] 
Soils, Argentina  218L  8   77  11  11  1  [30] 
  73S    88  4  8  0   
  70N    78  9  10  3   
Dried vine berries, 
Argentina 
5    0  0  100  0  [31] 
Grain, smoked dried 
meat products, 
Croatia 
96    0  10  5  85  [32] 
Corn, wheat, feeds, 
Hungary 
32    0  0  59  41  [33] 
Sour lime, India  25    20  40  ?  ?  [34] 
Soils, Iran  58    21  7  22  50  [35] 
Peanuts, Israel  200    19  73  4  4  [36] 
Maize, Italy  62  8   45  21  13  21  [37] 
Almonds, Portugal  15  1   20  0  0  80  [38] 
Feeds, Queensland  31  7   65  3  22  10  [39] 
Cocoa beans, Spain  100  20   15  32  17  36  [40] 
Maize, US  19    58  5  16  21  [41] 
Soils, US  774L    71  <1  12  16  [42] 
  309S    99  <1  <1  0   
Corn, nuts, animals 
and humans, Brazil, 
Uganda, US 
54    26  7  26  41  [43] 
a:  Number of total strains used in the calculation. L indicates strains that produce large sclerotia;  
S, small sclerotia and N, no sclerotia. 
b:  Number of strains that produce B- and G-type aflatoxins not included in the calculation. 
 
CPA and aflatoxins often co-contaminate crops [41,42,44–48]. The source of these mycotoxins is 
complicated by the fact that both aspergilli and penicillia are often found in the same crop and as well 
as after grain storage [49–53]. The most important aflatoxin producers are members in the Aspergillus 
section Flavi, particularly A. flavus, A. parasiticus, and A. nomius. Some strains of other members such 
as A. pseudotamarii [54], A. tamarii, A. toxicarius, and A. bombycis [55] also have been reported to 
produce aflatoxins. A. flavus has been divided into two subtypes based on sclerotial size [56–58]. The Toxins 2009, 1                 
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type with small sclerotia (SB or A. flavus Group IB) is found together with the L-morphotype (large 
sclerotia > 400 um) as crop and soil contaminants on all continents except Antarctica. Small sclerotia-
producing isolates from crops in Thailand that resemble A. flavus SB strains but produce both B- and 
G- aflatoxins have been called A. flavus var. parvisclerotigenus [59]. This taxonomic identification has 
never been recognized as authoritative, and in an independent investigation of Aspergillus section 
Flavi isolates from Thailand certain isolates with small sclerotia and the ability to produce both B- and 
G- aflatoxins have been identified as a variant clade of A. nomius rather than A. flavus [60]. Atypical 
A. flavus isolates (also called strain SBG or A. flavus Group II), which produce small sclerotia and are 
intermediate between A. flavus and A. parasiticus have been identified in soil and agricultural samples 
from West Africa, Argentina and Australia [28,58,61]. These SBG isolates have recently been classified 
as A. minisclerotigenes and A. arachidicola [62]. Only A. minisclerotigenes produces CPA. Isolates of 
these new taxa are also possibly found in the United States (Texas) [58,61] and Europe (Italy, 
Portugal, and Spain) [37,38,40]. Since the original finding of CPA production by A. flavus [63], the 
relationship between CPA and aflatoxin production by A. flavus and the closely related A. parasiticus 
has been investigated. Typical A. flavus isolates can produce only B-type aflatoxins and CPA, and A. 
parasiticus always produces B- and G-type aflatoxins but never CPA [23]. Table 1 summarizes the 
ability of A. flavus isolates to produce CPA and aflatoxins from various regions of the world. The 
atypical B- and G-type producers are excluded in Table 1. As can be seen, the ability of A. flavus 
isolates to produce CPA varies greatly. The incidence of CPA production by A. flavus is high (>70%) 
in Argentina and in the United States (Table 1).  
 
3. Toxicological and Pathological Effects of CPA 
 
The toxicity of CPA is attributed to its ability to alter normal intracellular calcium flux through the 
specific inhibition of sarcoplasmic or endoplasmic reticulum calcium-dependent ATPase (SERCA) 
essential for calcium uptake as in the muscle contraction-relaxation cycle, which results in increased 
muscle contraction [64,65]. SERCA also plays a crucial role in other body cells. It serves a 
housekeeping function, maintaining high calcium in the endoplasmic reticulum and low cytosolic 
calcium. This calcium gradient is vital for the cell and controls proliferation, differentiation and cell 
death. Most recent evidence shows that CPA inhibits the calcium pump by blocking the calcium access 
channel and immobilizing a subset of four transmembrane helices of the ATPase [66]. Besides the 
specific inhibition of ATPase activity, CPA induced various pathological lesions in test animals [19].  
In rats, intraperitoneal injection of CPA has been reported to cause lesions of the liver, kidney, 
pancreas, spleen, and heart [67]. The oral LD50 value for CPA in nonpregnant mice was 64 mg/kg 
body weight, and the toxicity syndromes included ptosis, hypokinesia, hypothermia, tremor, cessation 
of food and water intake and resulting cachexia. The intensity of these toxic syndromes was dose-
dependent. In pregnant mice, a single oral pulse dose of CPA (15 to 50 mg/kg) decreased body weight 
gain and the pregnancy rates significantly [68]. In feeding studies broiler chickens fed 100 ppm of 
CPA had a high mortality rate and decreased weight gain. Postmortem examination showed that the 
chickens had proventricular lesions characterized by mucosal erosion and hyperemia, yellow foci in 
livers and spleens. Microscopic examination of tissues showed ulcerative proventriculitis, mucosal 
necrosis in the gizzard, and hepatic and splenic necrosis and inflammation. Chickens fed 50 ppm CPA Toxins 2009, 1                 
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had thick mucosa and dilated proventricular lumens as well as hyperplasia of the proventricular 
mucosal epithelium. CPA at 10 ppm, however, did not cause significant lesions [22]. Dogs 
administered CPA at 0.5 mg/kg or 1.0 mg/kg died before the end of 90-day study period, which 
suggests a much lower no-observable-effect level (NOEL) than other small animals. Gross lesions of 
diffuse hyperemia with focal areas of hemorrhage and ulceration and microscopic lesions of necrosis, 
vasculitis, lymphoid necrosis, and karyomegaly in organs were apparent [69]. Surprisingly, among the 
large mammals, pigs appear to be quite sensitive to CPA with a NOEL of approximately   
1.0 mg/kg [70]. 
The effects of CPA (50 mg/kg) and aflatoxin (3.5 mg/kg) on broiler chickens, in most cases, were 
additive [71]. Chickens treated with CPA and aflatoxin had increased weights of the liver, kidney, and 
pancreas, showed signs of proventriculitis, had decreased concentrations of serum albumin and 
phosphorus, and increased concentrations of blood urea nitrogen and serum glutamic oxalacetic 
transaminase. Postmortem examination showed that the chickens fed CPA and aflatoxin exhibited 
similar pathological effects as those fed CPA alone, which included thickened mucosa and dilated 
proventricular lumens, hard fibrotic spleen, and atrophy of the gizzard. 
The IC50 of CPA on cell proliferation was 40-fold lower than ochratoxin (OTA) in an in vitro test 
using purified lymphocytes from piglets [72]. The combined effect of CPA and OTA based on IC20 on 
the proliferation of porcine lymphocytes was additive [73]. The individual and combined effect of 
CPA (34 mg/kg) and OTA (2.5 mg/kg) to broiler chickens were examined [74]. CPA reduced body 
weight to about 80% of the control, but it did not affect the relative weight of liver, kidney, pancreas 
except for proventriculus. The interaction of CPA and OTA was additive. The pathological lesions 
were similar to those caused by CPA and aflatoxin. Animals had increased weights of liver, kidney, 
pancreas, and proventriculus, decreased serum total protein and albumin, and increased triglycerides, 
uric acid and creatine kinase activity; creatine is important in maintaining the ATP level for skeletal 
muscle contraction. Postmortem examination revealed similar pathological lesions as those caused by 
CPA and aflatoxin. 
The feeding of CPA (34 mg/kg) and T-2 toxin (6 mg/kg) also caused reduced performance and 
adversely affected the health of broiler chickens [75]. A synergistic interaction between CPA and T-2 
for relative liver and kidney weights, serum cholesterol and triglyceride concentrations was observed. 
This combination also affected the 3-week body weight significantly. CPA and T-2 can induce cell 
death in lymphoid organs [76]. The immunopathological effect of 10 ppm CPA and 1 ppm T-2 in 
combination included decreases in both thymic CD8
+ lymphocyte and splenic CD4
+ and CD8
+ 
lymphocytes [77]. 
CPA is not a potent acute toxin because its oral LD50 in rats is in the range of 30 to 70 mg/kg 
[68,78]. Few incidents of animal mycotoxicosis have been reported because of the benign nature of 
CPA, the small amounts usually present, or the fact its effects may be masked by other concurrent 
mycotoxins. Both CPA and aflatoxins were isolated from peanut meal related to the turkey ‘X’ disease 
that caused the death of 100,000 turkeys in England in the early 1960s [79,80]. Although aflatoxins 
were regarded as the main culprit, CPA likely contributed to some of the observed pathological 
clinical signs, such as catarrhal or haemorrhagic enteritis and opisthotonus that are not characteristic of 
aflatoxicosis [79,81].  Toxins 2009, 1                 
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Despite the CPA-induced pathological effects in test animals, field incidents of CPA mycotoxicoses 
in humans have not been reported. Nonetheless, it has been speculated that CPA may be associated 
with ‘kodo poisoning,’ a toxic reaction characterized by nausea, vomiting, depression, intoxication and 
unconsciousness after consumption of CPA-contaminated Kodo millet in some parts of North India 
[78,82]. Based on a NOEL of 1 mg/kg/day and taking into consideration species variability, for 
humans approximately 10 μg/kg/day or 700 μg/day was suggested as the maximum acceptable daily 
intake (ADI) dose [19]. 
 
4. Biosynthesis of CPA 
 
Chemically, CPA belongs to the family of indole-tetramic acid secondary metabolites.   
P. griseofulvum Dierckx (originally called P. cyclopium) showed the maximal rate of CPA production 
after cessation of growth in Czapek’s medium. Research to elucidate the mechanism of CPA 
biosynthesis was carried out primarily in this strain in the 1970s. The origin of the carbon skeleton of 
CPA was established by feeding studies using radiolabeled substrates [83]. Chemical degradation 
analysis indicated that CPA is derived from tryptophan, a C5-unit formed from mevalonic acid and 
two molecules of acetic acid. The incorporation efficiencies of sodium [1-
14C]acetate, [2-
14C] 
mevalonic acid, and indole-labeled tryptophan were 3.5%, 7.0%, and 24.7%, respectively. The 
efficient incorporation of labeled tryptophan strongly suggested that it is a direct precursor of CPA. 
Further studies showed that all carbon atoms of the tryptophan were incorporated into CPA [84]. The 
presence of both β-CPA (bis-secodehydrocyclopiazonic acid) and CPA in mycelia suggested that   
β-CPA may be a precursor [85]. As further evidence for β-CPA being the precursor, the time-course of 
metabolite production showed that, when only trace amounts of CPA were produced, β-CPA 
predominated, while as CPA formation increased, the amount of β-CPA declined. After feeding   
[1-
14C]acetate-labeled β-CPA 67% was converted to CPA, while 18% remained as β-CPA [83]. The 
compound  γ,γ-dimethylallyltryptophan was known to be a precursor of ergot alkaloids [86–88]. 
Incubation of a cell-free-extract (CFE) with a mixture of radiolabeled [
3H]tryptophan and [1-
14C] 
dimethylallyl diphosphate (DMAPP) did not yield CPA labeled with either 
3H or 
14C although the 
resulting β-CPA contained 19% of the added 
14C, but no 
3H [89]. This result showed that the labeled 
DMAPP, but not tryptophan could be incorporated into β-CPA by the CFE. This study showed that 
CPA formation was different from ergot alkaloid biosynthesis, in the latter biosynthesis involves direct 
prenylation of tryptophan by DMAPP [86,90]. Subsequent studies found that the substrate for DMAPP 
in the CFE was α-acetyl-γ-(β-indolyl)methyltetramic acid (cycloacetoacetyl-L-tryptophan, cAATrp) 
[84]. The CFE converted exogenously supplied cAATrp and DMAPP into β-CPA in 1:1 stoichiometry. 
The responsible enzyme in the CFE was designated as cycloacetoacetyltyptophanyl dimethylallyl 
transferase. This enzyme, also called β-CPA synthase or dimethylallyl cycloacetoacetyl typtophan 
synthase (DCAT-S) was purified by McGrath et al. (1977). It has a molecular weight of 95 kDa with 
an isoelectric point of 5.3. Its concentration reached a maximum at 60 hr during fermentation. This 
synthase is very specific for DMAPP and cAATrp and could not use isopentenyl diphosphate (IPP, an 
isomer of DMAPP), tryptophan or N-acetyltryptophan as substrates [91]. The dimethylallyl tryptophan 
synthases of Clavices purpurea,  Aspergillus fumigatus, Aspergillus nidulans and Malbranchea 
aurantiaca for alkaloid biosynthesis are α2 dimers [86,92] suggesting that the β-CPA synthase is also Toxins 2009, 1                 
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likely to be a dimer. The enzyme(s) for the formation of cAATrp was never isolated from   
P. griseofulvum Dierckx. Schabort et al. [93] isolated five isozymes, designated as β-cyclopiazonate 
oxidocyclase that catalyzed oxidation and cyclization of β-CPA to CPA; each of the β-cyclopiazonate 
oxidocylases has a covalently linked flavin. Spectrophotometric titration studies of oxidized   
β-cyclopiazonate oxidocyclase with substrate analogs showed that the NH group in the tetramic acid 
residue is involved in binding to the active site [94,95]. 
 
4.1. The mevalonate pathway key to CPA formation in A. flavus 
 
Mevalonate is the primary precursor of DMAPP, which is also a major component in the production 
of terpenoids. The biosynthetic steps leading to the formation of mevalonic acid have been well 
characterized [96] and are shown in Scheme 1. They include condensation of acetyl-CoA and 
acetoacetyl-CoA by 3-hydroxy-3-methylglutaryl (HMG)-CoA synthase and a subsequent reduction by 
HMG-CoA reductase.  In eukaryotes, conversion of mevalonic acid to DMAPP involves two 
consecutive phosphorylations at position C5 by mevalonate kinase and phosphomevalonate kinase, 
respectively [97]. The subsequent decarboxylation carried out by diphosphomevalonate decarboxylase 
(or mevalonate-5-diphosphate decarboxylase), followed by dehydration produces isopentenyl 
diphosphate (IPP). IPP is a common intermediate for a number of pathways including those for the 
synthesis of terpenoids, steroids and carotenoids, and prenyl moieties of sirodesmin and ergot 
alkaloids. IPP is then isomerized by IPP isomerase to DMAPP, a potent electrophile [98]. DMAPP can 
alkylate other molecules, including IPP, to generate a variety of isoprenoid compounds found in nature 
such as plant hormones, mycotoxins, antimicrobial agents, and pharmaceutically important antibiotics.  
Scheme 1. Biosynthesis of dimethylallyldiphosphate (DMAPP). 
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The availability of full genome sequences for many organisms makes it possible to locate 
physically linked genes in a genome and to quickly obtain gene copy number. The genome sequences 
of A.  oryzae RIB40 (ATCC 42149) and A. flavus NRRL3357 are available for such analysis at 
http://www.bio.nite.go.jp/dogan/Top and http://www.aspergillusflavus.org/genomics/, respectively. 
Both genomes are about 37 Mb and organized in eight chromosomes [99,100]. These genome 
databases provide a remarkable wealth of information about identity, function, and physical location of 
many genes. Candidate genes involved in the anabolism and catabolism of mevalonic acid thus can be 
readily identified from respective genome databases (Table 2). The genes encoding key enzymes in 
DMAPP biosynthesis are not clustered and appear as multiple copies. There are two copies of genes 
encoding 3-hydroxy-3-methylglutaryl (HMG)-CoA synthase and HMG-CoA reductase and one copy 
each of genes encoding mevalonate kinase, phosphomevalonate kinase, and diphosphomevalonate 
decarboxylase. The predicted enzymes contain a conserved Gly/Ser-rich region probably involved in 
the binding of ATP known as a GHMP (abbreviations from their substrates, galacto-, homoserine, 
mevalonate and phosphomevalonate) kinase N terminal domain as well as a GHMP kinase C terminal 
domain. The mevalonate kinase gene and the diphosphomevalonate decarboxylase gene are about   
190 kb apart on chromosome 3, and the phosphomevalonate kinase gene is 50 kb from one of the two 
HMG-CoA synthase genes on chromosome 8. The two IPP isomerase genes are located on 
chromosome 3 and about 300 kb apart.  
 
Table 2. Predicted loci associated with the metabolism of mevalonic acid. 
Enzyme  Gene Locus
a  Location 
3-Hydroxy-3-methylglutaryl-
CoA synthase 
AFL2G_02388.2 
AFL2G_11649.2 
Contig 2, 2508858~2510466 − 
Contig 14, 1056212~1057748 − 
  AO090003000611  
AO090010000487 
Chromosome 2, SC003,1640889~1642497 + 
Chromosome 8, SC010, 1307684~1309220 − 
HMG-CoA reductase  AFL2G_08234.2  
AFL2G_12082.2  
Contig 9, 779011~783044 –  
Contig 15, 462348~465804 – 
  AO090120000217  
AO090103000311 
Chromosome 5, SC113, 541346~544055 – 
Chromosome 8, SC103, 805908~807609 + 
Mevalonate kinase   AFL2G_04604.2  Contig 4, 2076279~2077883 − 
  AO090023000793  Chromosome 3, SC023, 2058446~2060050 – 
Phosphomevalonate kinase   AFL2G_11633.2  Contig 14, 1009373~1011005 – 
  AO090010000471  Chromosome 8, SC010, 1260354~1261854 – 
Pyrophosphomevalonate 
decarboxylase 
AFL2G_04673.2  Contig 4: 2266676~2268145 – 
  AO090023000862  Chromosome 3, SC023, 2250974~2252258 − 
Isopentenyl pyrophosphate 
isomerase 
AFL2G_04341.2 
AFL2G_04245.2 
Contig 4, 1322573~1323720 +  
Contig 4: 1026352~1027394 + 
  AO090023000500 
AO090023000391 
Chromosome 3, SC023, 1306204~1307211 + 
 Chromosome 3, SC023, 1004129~1005046 + 
a: AFL2G indicates A. flavus genes and AO indicates A. oryzae genes. 
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4.2. The gene cluster involved in CPA biosynthesis is adjacent to the aflatoxin gene cluster in   
A. flavus/oryzae 
 
The aflatoxin gene cluster of A. flavus NRRL3357 resides in a subtelomeric region on chromosome 
3. Even before the genome sequences of A. oryzae and A. flavus became available it was suspected that 
the genes involved in CPA production are located close to the aflatoxin gene cluster because many  
A. flavus strains unable to produce aflatoxins also did not produce CPA. Further analysis found that 
such isolates lost large portions of or the entire aflatoxin gene cluster up to the telomere [101].   
A. oryzae is closely related to A. flavus, and some strains also produce CPA [15]. In the effort to 
generate A. oryzae mutants that do not produce aflatoxins, CPA, kojic acid, and 3-nitropropionic acid 
for producing polypeptides, Christensen et al. [102] gamma-irradiated A. oryzae BZ14, an isolate 
derived from A. oryzae IFO 04177, which contains the aflatoxin gene cluster. They obtained two  
CPA-negative mutants, BECh1 and BECh 2, which lost the aflatoxin pathway aflR and omtA genes. 
Because  aflR and omtA are 22 kb apart in the genomes  of  A. flavus and A. parasiticus, gamma 
radiation treatment must have caused deletion of a large portion of DNA containing genes encoding 
proteins involved in aflatoxin biosynthesis and CPA biosynthesis. From this study it was suspected 
that part of the deleted region is associated with CPA production. Christensen et al. [103] later isolated 
the dimethylallyl-cycloacetoacetyl-L-tryptophan synthase (DCAT-S) gene from an A. oryzae A1560 
(=IFO 04177) isolate. Disruption of this gene resulted in the loss of CPA production. 
Figure 2. Schematic representation of the PKS-NRPS involved in synthesis of cAATrp. 
The different domains are shown in the arrow (KS, ketosynthase; AT, acyl transferase;  
DH, dehydratase; MeT, methyltransferase; ER, enoyl reductase; KR, ketoreductase;   
ACP, acyl carrier protein attachment site; C, condensation domain; A, adenylation domain; 
T, thiolation domain; R, releasing domain). Brackets indicate the domains are defective. 
The numbers below the arrow indicate approximation amino acid distance from the   
N-terminus for the domains. 
1              385               870                             2360 2425             2793                 3392 3545                  3843
KS AT (DH) (MeT) (ER) (KR)
A
C
P
C T A R
1              385               870                             2360 2425             2793                 3392 3545                  3843
KS AT (DH) (MeT) (ER) (KR)
A
C
P
C T A R
 
 
In A. oryzae RIB40, which is unable to produce CPA, the aflatoxin gene cluster boundary gene 
norB is about 19 kb from the telomere at one end on chromosome 3 (Figure 3) suggesting that the 
DCAT-S gene is located between the aflatoxin gene cluster and the telomere. In the genome of   
A. oryzae NBRC 4177 (=IFO 04177), a CPA-producing strain, an additional region is present 
extending beyond the telomere in the RIB40 strain (Figure 3). Tokuoka et al. [15], using PCR profiling 
with oligoprimers derived from the same region in the A. flavus NRRL3357 genome sequence 
combined with an inverse PCR technique, identified the telomeric repeat and determined that the size 
of the region in A. oryzae NBRC 4177 extending beyond the telomere of A. oryzae RIB40 is about  
17 kb. Sequencing of the region around the RIB40 telomere in A. oryzae NBRC 4177 revealed a gene 
predicted to encode a hybrid polyketide synthase (PKS)-nonribosomal peptide synthase (NRPS). This 
pks-nrps gene is 11.7 kb and lacks introns. In addition, other genes in this region include: cpaB Toxins 2009, 1                 
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(encoding the DCAT-S), cpaC, predicted to encode a cytochrome P450 monooxygenase, a gene 
possibly encoding a methyltransferase, and cpaT, predicted to encode a transporter. As with other 
secondary metabolite gene clusters, clustering of genes may allow efficient coordinated regulation of 
gene expression when CPA production is necessary.  
Extensive PCR profiling of the 100-kb subtelomeric region of A. flavus strains of various 
chemotypes and closely related A. parasiticus strains, which produce aflatoxins, but not CPA, 
suggested that a CPA biosynthesis cluster is next to the aflatoxin gene cluster [13]. Four genes were 
characterized in this putative CPA gene cluster by gene disruption: maoA, predicted  to  encode a 
monoamine synthase, dmaT, the gene encoding the dimethylallyltryptophan synthase, pks-nrps, and a 
Zn2Cys6 transcription factor-encoding gene, ctfR1 (Figure 3). Consistent with studies performed on  
A. oryzae, disruption of dmaT (=the DCAT-S gene) and pks-nrps abolished CPA production [15,102]. 
Knockout studies confirmed that the gene maoA is also required for CPA biosynthesis. Surprisingly, 
disruption of ctfR1, which was expected to be required for transcriptional regulation of the CPA cluster 
genes, did not affect CPA production. A 3-kb region between the aflatoxin gene cluster and maoA in  
A. flavus did not contain ORFs likely to encode proteins related to CPA biosynthesis (see Figure 3). 
Therefore, maoA, dmaT, pks-nrps constitute the CPA gene cluster in A. flavus. A search of the putative 
promoter region for the pks-nrps for potential Zn2Cys6 protein binding sites revealed a sequence,   
5’-TCGTGGACGA-3’, which is quite similar to AflR-binding sites [104]. If AflR is acting as the 
pathway specific regulatory protein for both the aflatoxin and the CPA gene clusters, this would 
explain their apparent co-regulation under similar media conditions and the reason why proximity to 
the aflatoxin gene cluster is maintained. 
 
5. Characterization of the Enzymes Involved in CPA Biosynthesis 
 
5.1. Formation of cAATrp by CpaS, a hybrid PKS-NRPS 
 
Formation of the first stable intermediate in CPA biosynthesis, cyclo-acetoacetyl-L-tryptophan 
(cAATrp), in A. flavus/oryzae requires catalysis by the 431 kDa multifunctional CPA synthase (CpaS 
or CpaA), a PKS/NRPS polypeptide with seven functional and four non-functional catalytic domains 
[14,15] (Figure 2) The PKS portion of CpaS contains three functional domains, a ketosynthase (KS), 
an acyl transferase (AT), and an acyl carrier protein (ACP) domains that catalyze formation of 
acetoacetyl-CoA by condensation of one molecule of acetyl-CoA with one molecule of malonyl-CoA. 
Domains of dehydratase (DH), methyltransferase (MT), enoylreductase (ER) and ketoreductase are 
present in the CpaS but lack critical amino acids necessary for catalytic activity [14]. After 
condensation of two molecules of acetate by the KS, the acetoacetyl moiety is tethered on ACP. The 
NRPS portion of CpaS shown in Figure 2 has catalytic domains common to many NRPSs, including a 
condensation domain (C, amino acids 2501–2793), an adenylation domain (A, amino acids   
2980–3392) to activate an amino acid for loading, a thiolation domain (T, amino acids 3481–3546) 
that is an attachment site of the growing peptide on the phosphopantetheinylated peptidyl carrier 
protein (PCP), and a releasing domain (R, amino acids 3593–3619) to release the product peptide from 
the enzyme. The biosynthesis steps leading to cAATrp are shown in Scheme 2. Toxins 2009, 1                 
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Scheme 2. Conversion of acetylCoA to cAATrp by the hybrid PKS-NRPS. A. Formation 
of the cAATrp precursor catalyzed by the KS, AT, ACP, A, and C domains. B. Dieckmann 
cyclization to form cAATrp catalyzed by the R domain. 
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Amino acid selection by the A domain is dependent on signature amino acids in the domain that 
have not been well defined [105]. However a tool is available that predicts whether or not large 
(aromatic amino acids) or small amino acids will be accepted by the A domain [106]. Prediction for 
CpaS is that large amino acids such as Trp or Phe will be recognized by its A-domain. How Trp rather 
than Phe is recognized by the CpaS A-domain has not been determined. During synthesis of cAATrp, 
the adenylation domain activates the substrate Trp which is then transferred to the pantetheine cofactor 
of the neighboring peptidyl carrier protein (PCP) domain (the T domain in Figure 2) [107].  
Gulick [105], in reviewing the required conformation dynamics for catalysis by NRPSs, found 
evidence for a domain alternation strategy between the A and T domains that consists of two catalytic 
steps: the first involving the initial adenylation of the amino acid carboxylate moiety to form an   
acyl-AMP intermediate and the second involving formation of the thioester. He suggested that the 
enzymes use a 140° domain rotation to present opposing faces of the two domains to the active site in 
order to allow both partial reactions. The crystal structure of a four-domain NRPS SrfA-C protein, 
which is similar to CpaS, was determined and demonstrated that the A domain is rotated away from 
the N-terminal T domain, thereby allowing the PCP domain to interact with the neighboring C domain. 
The PCP domain is not positioned so that it could donate the pantetheine arm to either the A domain or 
the R domain. 
The C domains of NRPSs are known to catalyze amide bond formation between two PCP-tethered 
amino acids [108,109]. For CpaS, condensation occurs between the ACP-tethered acetoacetyl moiety Toxins 2009, 1                 
 
 
85
and the PCP-tethered tryptophan and forms an amide bond. Condensation requires the involvement of 
the highly conserved HHXXXDX14Y motif found in all modular C domains [110]. The Asp and 
second His were found to be essential for catalytic activity. Following condensation the substrate 
remains tethered to the PCP phosphopantetheinyl arm in the T domain. 
Comparisons of both hybrid PKS-NRPS and NRPS enzymes show that the most downstream 
domain of the NRPS module acts as the chain-terminating module. Therefore, the release of the 
condensation product acetoacetyl-Trp is likely to be mediated by such an R domain. The role of the R 
domain in the release of the metabolite from the PKS-NRPS has recently been found to occur without 
the expected NADH/NADPH reduction even though the R domain contains an NADH/NADPH 
binding domain (GXXG/SXXG) near its N-terminus [111]. However, the domain lacks a functional 
short chain dehydrogenase/reductase (SDR) catalytic triad (Ser-Tyr-Lys) characteristic of similar 
NRPSs and other enzymes (aldehyde reductase, epimerases) known to use such domains for thioester 
and ester hydrolysis. In CpaS, the Tyr is replaced by Leu in this triad which would prevent catalytic 
function as a reductase. Other amino acids further toward the C-terminus of the R-domain were found 
to be necessary for catalysis, in particular, Asp3803 and His3843. The His residue could be involved in 
proton abstraction necessary to form the resonance-stabilized acetoacyl carbanion shown in Scheme 
2A. It is this carbanion that attacks the thioester carbonyl by Dieckmann condensation to cyclize 
acetoacetyl-Trp and release it from PCP to form the indole tetramate, cAATrp.  
 
5.2. Conversion of cAATrp to β-CPA  
 
Conversion of cAATrp to β-CPA (Scheme 3) involves alkylation of the C-4 position of the Trp 
indole ring by DMAPP, a reaction catalyzed by cycloacetoacetyltyptophanyl dimethylallyl transferase 
[91] encoded by the CPA-cluster gene, dmaT. The transferase also is called dimethylallyl 
cycloacetoacetyl typtophan synthase (DCAT-S) or designated as CpaD [111]. A. flavus and A. oryzae 
DMATs consist of 437 amino acids with a calculated molecular weight of 49 kDa, and the functional 
form likely is a dimer as reported for many dimethylallyl tryptophan synthases involved in the 
synthesis of alkaloids. There are at least nine dmaT homologs in the A. flavus genome, but only the 
dmaT in the CPA gene cluster is associated with a pks-nrps gene.  
Involvement of dimethylallyl tryptophan synthases (DMATs) in other biosynthetic processes has 
been well documented. Some of these DMATs may be used in synthesis of alkaloids related to ergot, 
where the first committed step in the biosynthesis is tryptophan prenylation. Since disruption of the 
CPA-cluster dmaT prevents CPA biosynthesis, the DMAT in the CPA cluster appears to be the only 
DMAT able to catalyze prenylation of cAATrp. The presence of dmaT in the CPA gene cluster 
supports the assembly-line nature of β-CPA biosynthesis similar to those characterized for NRPSs in 
prokaryotes. Catalytic activity has recently been studied by analyzing the crystal structure of a 
complex of A. fumigatus DMAT with L-tryptophan [112].  Toxins 2009, 1                 
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Scheme 3. Conversion of cAATrp to α-CPA. 
 
 
The protein forms a β/α barrel fold called a prenyltransferase barrel. Enzymes with similar structure 
are found in bacteria but have no sequence similarity to fungal DMATs. The crystal structure revealed 
that dimethylallyl diphosphate is positioned selectively in the enzyme over position 4 of the Trp indole 
nucleus (Scheme 3). The reaction catalyzed by DMAT is an electrophilic alkylation, (Friedel-Crafts 
alkylation), of an aromatic ring. The energy barrier for cation formation that precedes the alkylation is 
overcome by tight interactions with Arg and Lys residues in the catalytic pocket that offset the 
diphosphate negative charges. The resulting carbocation is stabilized by five Tyr residues to provide a 
hydrophobic pocket that prevents reaction of the carbocation with water. Just as in a typical   
Friedel-Crafts reaction Mg
2+ facilitates the alkylation. 
 
5.3. Conversion of β-CPA to α-CPA is catalyzed by the monoamine oxidase MaoA (CpaO) 
 
The final step in the biosynthesis of  α-CPA is the dehydrogenation of β-CPA resulting in 
intramolecular ring closure (Scheme 3, bottom). The enzyme involved in this conversion (CpaO) is a 
FAD-dependent oxidoreductase that has some of the properties of typical monoamine oxidases. Early 
studies suggested that the CPA oxidoreductase first generates an unstable eneimine which then 
undergoes intramolecular cyclization [94,95,113,114]. The role of the flavin prosthetic group in 
catalysis by FAD-dependent oxidases has been the subject of much study and although the ring-
closure appears surprisingly simple the mechanism for the catalysis is still under scrutiny [115–117]. 
The deprotonated (rather than the protonated) amine moiety on the substrate initially binds to the 
active site on the monoaminoxidase and is oxidized to the protonated imine with the covalently bound 
FAD cofactor being reduced to its hydroquinone form. To complete the catalytic cycle, the reduced 
FAD cofactor reacts with O2 to generate oxidized flavin and H2O2. Characterized monoamine oxidases 
exist as membrane-bound dimeric proteins. In human monoamine oxidase A (MaoA), substrate Toxins 2009, 1                 
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binding and oxidation occur in elongated cavities extending from the flavin site at the core of the 
enzyme to the surface of the protein on the opposite side of the FAD adenosine ring. From crystal 
structure determinations, the cavity of the enzyme is hydrophobic. C-H bond cleavage is catalyzed by 
monoamine oxidases to form the protonated imine; the cleavage could involve transfer of a proton, a 
hydride or a hydrogen atom to the flavin.  
Unlike the usual oxidations catalyzed by monamine oxidases which involve proton transfer to the 
flavin [116], the oxidation of β-CPA by CpaO could be initiated by a hydride shift mechanism similar 
to that postulated for cyclizations catalyzed by the berberine bridging enzyme oxidases [116,118–120]. 
The steps most likely involve hydride transfer to the N4-flavin nitrogen to generate a stabilized cation 
that undergoes the ring closure as shown in Scheme 4. A radical intermediate could just as easily 
explain the ring closure steps. However, Edmondson et al. [116] suggested that a polar mechanism for 
monoamine oxidase catalysis fits theoretical calculations best. Formation of an unstable eneimine 
intermediate as previously suggested [95] is unlikely and ring formation probably occurs immediately 
upon hydride transfer without accumulation of an intermediate.  
Scheme 4. Possible mechanism for oxidative ring-closure of β-CPA to α-CPA by the 
flavin-dependent monoamine oxidase, MaoA (CpaO). 
 
 
6. Genetic Diversity in CPA Biosynthesis of A. flavus and A. oryzae 
 
The gene preceding maoA of the CPA gene cluster in A. oryzae RIB40 and NBRC 4177 encodes a 
P450 monooxygenase while in the same relative location in A. flavus NRRL3357 and AF13 no such a 
gene is present (Figure 3). The unique location of this p450 gene (=cpaC) in A. oryzae is reminiscent 
of the same gene organization in the Aspergillus S BG isolate BN008R (ATCC MYA379) collected 
from Benin, West Africa [61,121]. A comparison of the 12 kb region beyond the norB gene in 
BN008R to the corresponding region in RIB40 shows that they share > 95% nucleotide identity   
(>98% in the maoA and the p450 coding regions). A. oryzae mutants with p450 deleted failed to 
produce mono- and dihydroxy CPA when compared to the wild type [122]. Since the p450 gene is 
missing in CPA-producing A. flavus NRRL3357 and AF13 (Figure 3), it is not directly involved in 
CPA biosynthesis. It is not known whether A. oryzae RIB40 gained the p450 gene or A. flavus 
NRRL3357 lost the p450 gene. Toxins 2009, 1                 
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Figure 3. Partial and complete CPA clusters in different strains of A. flavus and A. oryzae. 
The AF biosynthesis cluster is shown above the scale (kb). 
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RIB40 and NRRL3357 exhibit other unique differences; the former has the type I deletion in its 
norB-cypA region, an S-strain signature, while the latter has the type II deletion that is often associated 
with aflatoxigenic L-strain A. flavus isolates [123]. They also have distinct single nucleotide 
polymorphisms in the omtA and dmaT genes involved in aflatoxin and CPA biosynthesis, respectively 
[58,123] (and unpublished results). A. flavus populations are genetically diverse. A. oryzae is believed 
to be selected or to have evolved from certain groups of nonaflatoxigenic A. flavus. A. oryzae strains 
are classified into three groups based on deletion patterns in the aflatoxin gene cluster [124,125]. 
Group 1 has all aflatoxin gene orthologs, group 2 has the region beyond the ver1 gene deleted but 
contains a DNA segment of unknown origin, and group 3 has the partial aflatoxin gene cluster up to 
the vbs gene (see Figure 3). Group 3 resembles the E, F, and G deletion patterns in nonaflatoxigenic 
and CPA-negative A. flavus isolates [101], which lack the genome region beyond the respective partial 
aflatoxin gene cluster (connected to telomeric repeat). Since the CPA gene cluster in A. oryzae resides 
next to the aflatoxin gene cluster as in A. flavus, group 3 likely has lost the CPA gene cluster. Group 2 
strain RIB62 has been confirmed to be lacking the CPA gene cluster resulting from a large deletion 
[125]. Some strains of group 1 A. oryzae still maintain the ability to produce CPA, such as NBRC 
4177 while other strains have lost the ability, such as RIB40 due to a truncation that caused the loss of 
more than half of the pks-nrps gene. 
A PCR survey of the strains of A. oryzae and A. flavus and related A. parasiticus and A. sojae 
(Table 3) showed that only isolates of nonaflatoxigenic and CPA-positive L-strain A. flavus, with the 
type I, S-strain genetic signature in a previously characterized clade, for example, MS1-1, NC3-6, 
SC3-5 and TX21-9 [123] also have the p450 gene.  
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Table 3. Sclerotial, genetic, and toxin-producing characteristics of isolates of Aspergillus species. 
Species  Strain 
Sclerotial 
Morphotype
a 
AF/CPA 
Production
b 
norB-cypA 
Pattern
c 
p450
d 
A. flavus  CA28  S  +/+  I  N 
  CA42  S  +/+  I  N 
  CA43  S  +/+  I  N 
  CA44  S  +/+  I  N 
  AF12  S  +/+  I  N 
  AF70  S  +/+  I  N 
  GA10-18  S  +/+  I  N 
  VA4-36  S  +/+  I  N 
  AF13  L  +/+  II  N 
  CA14  L  +/+  II  N 
  CA19  L  +/+  II  N 
  GA9-9  L  +/+  II  N 
  GA13-9  L  +/+  II  N 
  NRRL3357  L  +/+  II  N 
  VA2-9  L  +/+  II  N 
  LA4-5  L  −/+  I  N 
  SC6-9  L  −/+  I  N 
  TX9-8  L  −/+  I  N 
  GA4-4  L  −/+  II  N 
  LA10-4  L  −/+  II  N 
  MS1-1  L  −/+  I  Y 
  NC3-6  L  −/+  I  Y 
  SC3-5  L  −/+  I  Y 
  TX21-9  L  −/+  I  Y 
A. oryzae  NBRC 4177  ?  −/+  ?  Y 
  RIB40  N  −/−  I  Y 
  SRRC304  N  −/?  I  Y 
  SRRC493  N  −/?  I  Y 
  SRRC2044  N  −/?  I  Y 
A. parasiticus  BN009  L  +/−  intact  N 
  SRRC2043  L  +*/−  intact  N 
  SRRC2999  L  +/−  intact  N 
A. sojae  SRRC299  N  −/?  intact  N 
  SRRC1123  N  −/?  intact  N 
  SRRC1126  N  −/?  intact  N 
a: S and L indicate S-strain and L-strain isolates based on the size of sclerotia produced. 
b: I and II indicate type I and type II deletions in the norB-cypA region. 
c: The p450-specific oligonucleotides used in PCR, tgtgacggtggatggcgagc and tcaatggctttgtactccag, were 
derived from identical regions of A. oryzae RIB40 and Aspergillus SBG strain, BN008R. 
 
As mentioned earlier, atypical A. flavus SBG isolates have been classified into the new taxa of A. 
minisclerotigenes and A. arachidicola [62]. A. minisclerotigenes differs from A. arachidicola. in that it Toxins 2009, 1                 
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produces CPA like A. parvisclerotigenus, previously named A. flavus var. parvisclerotigenus by Saito 
and Tsuruta [59], which included largely SB strains and only a small number of SBG strains [56,59]. 
Genetic evidence shows that the β-tubulin gene sequence of the A. parvisclerotigenus strain, CBS 
121.62
T, isolated from Nigeria by Hesseltine et al. [56], is different from those of the A. 
minisclerotigenes strains and this strain produced other metabolites, such as A30461 and speradine A 
not produced by A. minisclerotigenes [62].  
Although Saito and Tsuruta [59], in their naming of A. flavus var. parvisclerotigenus, included 
morphologically similar SBG isolates obtained by Hesseltine et al. [56], Ehrlich et al. [60] considered 
the SBG isolates collected from different regions of Thailand by Saito and Tsuruta [59] a variant clade 
of A. nomius rather than A. flavus. The SBG Aspergillus BN008R isolated from Benin, West Africa [61] 
likely is A. minisclerotigenes. We hypothesize that the common ancestor of the aforementioned 
nonaflatoxigenic and CPA-positive L-strain A. flavus isolates and the group 1 A. oryzae that contain 
the p450 gene may be A. minisclerotigenes or A. flavus var. parvisclerotigenus. The loss of both B- 
and G-type aflatoxins renders them to be regarded as A. flavus due to the morphological and cultural 
similarities to other clades of A. flavus. Probably, two genetic variants are responsible for CPA 
production in A. flavus. One is the SB A. flavus strains that always have the type I norB-cypA deletion, 
and another is L-strain A. flavus strains with the type II deletion, which are either aflatoxigenic or 
nonaflatoxigenic. 
 
7. Possible Advantage of CPA to Fungi  
 
Like aflatoxins, the benefit of CPA to the producing fungi is not clear. CPA is an excellent chelator 
of iron. CPA production is greatest during the period preceding dormancy when growth has practically 
stopped. Because concentrations of free iron in soil are usually low, it would be beneficial to fungi to 
have a readily available supply of iron for subsequent growth. Riley and Goeger [126] speculated that 
stockpiles of CPA-chelated iron would be conducive to rapid fungal growth for occupying a niche in 
the saprophytic environments. Similar to a siderophore, which is an iron-chelating compound secreted 
by bacteria, fungi, and plants, CPA probably fulfilled partly this ion-chelating function long ago before 
a true siderophore took its place. Many siderophores are nonribosomal peptides and dissolve ions by 
chelation as soluble Fe
3+ complexes that are taken up by active transport mechanisms. In the A. flavus 
genome, in the same subtelomeric region where the CPA gene cluster resides, sidC and sidT (msf2) 
genes encoding a siderophore and a siderochrome-iron transporter, respectively, have been identified 
[13]. Their location, which is at a terminus of chromosome 3, suggests that they were acquired later 
than the CPA gene cluster to carry out the iron-chelating function. 
 
8. Conclusions 
 
The CPA and aflatoxin gene clusters are contiguous on the subtelomeric region of chromosome 3 in 
the A. flavus and A. oryzae genomes. The enzyme functions of the three CPA genes correlate well with 
current as well as previous studies of the biosynthesis of this indole-tetramic acid product. Although 
CPA is not a potent acute toxin and few incidents of mycotoxicoses have been reported, aflatoxin B1 is 
a potent carcinogen. Little is known about the synergistic effects of the two toxins and more research Toxins 2009, 1                 
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is needed especially because plans are being considered to apply nonaflatoxigenic A. flavus strains in 
large amounts to control aflatoxin contamination in corn, cottonseed, and peanuts and some A. oryzae 
strains used in food fermentation are capable of CPA production. With knowledge of the   
co-localization of the two gene clusters it is now easy to explain why strains of A. flavus and A. oryzae 
have different abilities to produce aflatoxin and CPA. This understanding has significant health 
implications. The genetic diversity of A. flavus and A. oryzae in the region adjoining the CPA gene 
cluster suggests a divergence of A. flavus from A. oryzae. We suggest that A. oryzae most likely 
descended from an ancestor that was the precursor of the Aspergillus S BG variant, while A. flavus 
descended from a precursor of A. parasiticus. 
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